Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we helped our client to understand the opportunities across Asia and other emerging markets using interactive outputs
Our client needed to understand why the use of statins in type 2 diabetes patients in South Korea, China, Thailand and other developing countries is low / sub-optimal.read more »How we used a hybrid qual-quant methodology to assess the market opportunity for a new rare disease treatment
The challenge: Our client is a recently established independent biopharmaceutical company specialising in small molecule development. They were developing a new oral compound for the treatment of a rare genetic disease for which the standard treatment is administered intravenously, however a large proportion of patients receive monitoring only or remain undiagnosed. Their objective was to successfully launch their product in order to provide clinically meaningful…read more »How we helped track and evaluate conference performance over time across multiple international events
Our client planned to have a significant presence at key global conferences over the course of a year. Find out how we effectively monitored perceptions of their brand across different regions over time.read more »
- Our latest white papersAre dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.read more »Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations
In this paper we examine the differences between behavioural and attitudinal approaches to segmentation and outline how integration of the two can best be achieved to strengthen segmentation solutionsread more »